Here are the key things you need to know about in the NZX markets over the past 24 hours. Changes are as at 3:00 pm and may change when the market closes at 4:45 pm.
WHAT THE NZX50 INDEX IS DOING
The NZX50 surged to its highest level in over two and a half years, climbing +2.0% +1.3% to close the trading week. This big move brings the index’s five-day gain to +2.6% +2.0% and extends its six-month increase to +11.0% 10.3%. Year-on-year, the NZX50 boasts a solid growth of +16.5% 15.8%.
THE MAIN GAINERS
There are 43 gainers in the market to close the week on a strong note. Leading the pack is a2 Milk (ATM, #11) with an extraordinary gain of +14.1%, driving its weekly performance to +15.8%. Year-on-year, a2 Milk's share price has climbed an impressive +43.4%. Investore Property (IPL, #45) follows with a solid +5.3% gain for the day, though it remains down -4.8% for the month. On a year-on-year basis, the company has increased by +8.2%. Market leader F&P Healthcare (FPH, #1) posted a +3.2% rise today, adding to its six-month growth of +33% and pushing its year-on-year performance to an outstanding +72%. Fletcher Building (FBU, #14) also gained +3.0% but continues to face challenges, down -29% year-on-year.
A2 Milk
Select chart tabs
THE MAIN DECLINERS
With 37 decliners today, Oceania Healthcare (OCA, #39) led the losses, falling -3.8%. Short-term performance shows declines of -1.3% over both the past five days and the last month, while year-to-date, the company holds a modest gain of +1.3%. Kathmandu Brands (KMD, #50) followed, dropping -2.3%, which extends its year-on-year decline to a steep -47%. The Warehouse Group (WHS, #49) slipped -1.9%, bringing its monthly decline to -5.6%, and its share price is down -39% year-on-year. Channel Infrastructure (CHI, #36) rounded out the list with a -1.7% fall today but remains up +12.1% over the last six months, contributing to a +17.3% year-on-year increase.
Oceania Healthcare
Select chart tabs
SMARTSHARES EFTs
1-day | 5-day | 6-month | YTD | 1Y | |
NZ Top 50 ETF (FNZ) | +1.1% | +2.0% | +8.9% | +5.6% | +9.3% |
NZ Top 10 ETF (TNZ) | +1.1% | +1.1% | +10% | +7.7% | +12.9% |
S/P NZX50 ETF (NZG) | +0.9% | +2.1% | +9.0% | +8.5% | +13.3% |
NZ Dividend ETF (DIV) | +0.5% | +0.4% | +6.1% | -0.2% | +1.6% |
KEY ANNOUNCEMENTS
Oceania Healthcare (OCA, #39) reported a solid interim performance for the six months ending 30 September 2024, with underlying EBITDA rising +2.7% to $38.6m and operating cashflow increasing +23.1% to $70.4m. The company achieved strong care suite sales, boosting capital gains by +34.9% to $38.2m, while reducing gearing to 37.5%. Development progress included delivering 106 new care suites and plans for an additional 118 units by year-end. CEO Suzanne Dvorak emphasised priorities in improving sales execution, streamlining developments, and enhancing care service profitability. Despite reporting a $(17.1)m NPAT loss due to impairments, Oceania remains focused on modernising its portfolio and expects dividends to resume once sales-driven debt reduction targets are met.
The a2 Milk Company (ATM, #11) has updated its FY25 revenue guidance to mid to high single-digit growth, reflecting stronger-than-expected performance driven by increased ingredient sales at MVM, favourable pricing, and improved English Label IMF and Liquid Milk sales. EBITDA margins are expected to remain consistent with FY24, with a softer 1H25 and a stronger 2H25. The company also introduced its first-ever dividend policy, targeting a payout ratio of 60-80% of normalised NPAT, with the initial interim dividend planned for February 2025 at 60%. Chair Pip Greenwood highlighted the company’s progress and financial resilience, while CEO David Bortolussi emphasised rewarding shareholders while maintaining growth-focused capital allocation. Future semi-annual dividends, with potential special payouts, will reflect evolving market conditions and financial priorities.
NZX50 Telecommunication Sector
Select chart tabs
Click on the chart title to find more about this sector, including its components.
We welcome your comments below. If you are not already registered, please register to comment.
Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.